Estrogen/progestogen Receptor
Estrogen and progestogen receptors are nuclear hormone receptors that mediate the effects of estrogen and progesterone, respectively. These receptors regulate various physiological processes, including reproductive function, bone density, and cardiovascular health. Estrogen and progestogen receptor modulators are extensively studied for their roles in hormone replacement therapy, contraception, and the treatment of hormone-responsive cancers. At CymitQuimica, we provide a comprehensive range of high-quality estrogen and progestogen receptor modulators to support your research in endocrinology, reproductive health, and cancer biology.
Read more
NXT629
CAS:1454925-59-7
NXT629 is a PPAR-α antagonist with anticancer activity, inhibiting PPARδ, and can be used in …
Formula:
C35H39N5O3S
Purity:
99.07% - 99.07%
Color and Shape:
Solid
Molecular weight:
609.78
Ref: TM-T12278
| 1mg | 242.00 € | ||
| 2mg | 357.00 € | ||
| 5mg | 593.00 € | ||
| 25mg | 1,637.00 € | ||
| 50mg | 2,137.00 € | ||
| 100mg | 2,745.00 € |
Estimated delivery in United States, on Monday 2 Jun 2025
OP-1074
CAS:1443752-76-8
OP-1074 is a pure antiestrogen and a selective degrader of ER, shows specific antiestrogenic activity …
Formula:
C29H31NO4
Purity:
98%
Color and Shape:
Solid
Molecular weight:
457.56
Ref: TM-T12312
| 25mg | 1,586.00 € | ||
| 50mg | 2,072.00 € | ||
| 100mg | 2,660.00 € |
Estimated delivery in United States, on Monday 2 Jun 2025
DS20362725
CAS:2735803-20-8
DS20362725 is an ERRα agonist with IC 50 of 0.6 μM for RIP140, used in …
Formula:
C19H22N2O2
Purity:
99.34%
Color and Shape:
Liquid
Molecular weight:
310.39
Ref: TM-T60759
| 25mg | 1,140.00 € | ||
| 50mg | 1,491.00 € | ||
| 100mg | 2,442.00 € |
Estimated delivery in United States, on Monday 2 Jun 2025
Palazestrant
CAS:2092925-89-6
Palazestrant, an antiestrogen and antineoplastic agent, effectively targets ER+/HER2+ cancer when used in conjunction with …
Formula:
C28H36FN3O
Purity:
97.55%
Color and Shape:
Liquid
Molecular weight:
449.6
Ref: TM-T72945
| 1mg | 279.00 € | ||
| 5mg | 685.00 € | ||
| 10mg | 938.00 € | ||
| 25mg | 1,444.00 € | ||
| 50mg | 1,882.00 € |
Estimated delivery in United States, on Monday 2 Jun 2025
ERRα antagonist-1
CAS:1072145-33-5
ERRα antagonist-1 (ERR+/- antagonist-1) is a high-affinity, selective antagonist of the estrogen-related receptor α (ERRα).
Formula:
C21H19N3S2
Purity:
100%
Color and Shape:
Solid
Molecular weight:
377.53
Ref: TM-T11230
| 2mg | 42.00 € | ||
| 5mg | 62.00 € | ||
| 10mg | 97.00 € | ||
| 25mg | 187.00 € | ||
| 50mg | 283.00 € | ||
| 1mL*10mM (DMSO) | 67.00 € |
Estimated delivery in United States, on Monday 2 Jun 2025
Estrogen receptor antagonist 8
CAS:2889370-92-5
Estrogen Receptor Antagonist 8 is an ER antagonist with anti-uterine activity and may be used …
Formula:
C25H21N3O4
Purity:
99.66%
Color and Shape:
Liquid
Molecular weight:
427.45
Ref: TM-T78646
| 1mg | 279.00 € | ||
| 5mg | 685.00 € | ||
| 10mg | 938.00 € | ||
| 25mg | 1,444.00 € | ||
| 50mg | 1,882.00 € | ||
| 100mg | 2,375.00 € |
Estimated delivery in United States, on Monday 2 Jun 2025
Capesaris
CAS:938067-78-8
Capesaris (GTX-758) is an oral estrogen receptor α agonist, used in prostate cancer research.
Formula:
C19H13F2NO3
Purity:
99.65%
Color and Shape:
Liquid
Molecular weight:
341.31
Ref: TM-T68292
| 1mg | 302.00 € | ||
| 5mg | 730.00 € | ||
| 10mg | 999.00 € | ||
| 25mg | 1,539.00 € |
Estimated delivery in United States, on Monday 2 Jun 2025
(E/Z)-GSK5182
CAS:2699724-40-6
GSK5182 is a racemic mix of (E/Z) isomers, a selective ERRγ inverse agonist (IC50: 79 …
Formula:
C27H31NO3
Purity:
97.58%
Color and Shape:
Solid
Molecular weight:
417.54
Ref: TM-T7709
| 1mg | 81.00 € | ||
| 5mg | 170.00 € | ||
| 10mg | 274.00 € | ||
| 25mg | 502.00 € | ||
| 50mg | 747.00 € | ||
| 100mg | 1,121.00 € | ||
| 1mL*10mM (DMSO) | 187.00 € |
Estimated delivery in United States, on Monday 28 Jul 2025
